These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 25967074

  • 1. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T, Tóth K, Nagy A, Szever Z, Kiss Á, Temesvári M, Háfra E, Garami M, Tapodi A, Monostory K.
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [Abstract] [Full Text] [Related]

  • 2. Relevance of CYP2C9 Function in Valproate Therapy.
    Monostory K, Nagy A, Tóth K, Bűdi T, Kiss Á, Déri M, Csukly G.
    Curr Neuropharmacol; 2019 Jun; 17(1):99-106. PubMed ID: 29119932
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.
    Ma B, Yang K, Li X, Su N, Yu T, Zou Y, Xu X, Wang F, Cheng J, Yan Z, Chen T, Zhang L.
    Ther Drug Monit; 2024 Aug 01; 46(4):503-511. PubMed ID: 38287884
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
    Yoon HY, Ahn MH, Yee J, Lee N, Han JM, Gwak HS.
    Eur J Clin Pharmacol; 2020 Aug 01; 76(8):1053-1058. PubMed ID: 32385545
    [Abstract] [Full Text] [Related]

  • 7. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L.
    Basic Clin Pharmacol Toxicol; 2017 Aug 01; 121(2):138-143. PubMed ID: 28273397
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.
    Song C, Li X, Mao P, Song W, Liu L, Zhang Y.
    Eur J Hosp Pharm; 2022 Jul 01; 29(4):198-201. PubMed ID: 32868386
    [Abstract] [Full Text] [Related]

  • 11. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury.
    Sun Y, Yu J, Yuan Q, Wu X, Wu X, Hu J.
    Scand J Trauma Resusc Emerg Med; 2017 Aug 25; 25(1):85. PubMed ID: 28841884
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ, Lluch-Fernández MD, Vaquero-Abellán M, Marchante-Serrano C, Jiménez C.
    Rev Neurol; 1997 Jul 25; 25(143):1037-44. PubMed ID: 9280630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X, Li X, Zhang T, Zhao L.
    Basic Clin Pharmacol Toxicol; 2018 Nov 25; 123(5):628-634. PubMed ID: 29791065
    [Abstract] [Full Text] [Related]

  • 18. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
    Tan L, Yu JT, Sun YP, Ou JR, Song JH, Yu Y.
    Clin Neurol Neurosurg; 2010 May 25; 112(4):320-3. PubMed ID: 20089352
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC.
    Nervenarzt; 1986 May 25; 57(5):314-8. PubMed ID: 3088461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.